Document Type : Original articles

Authors

National Focal Point of Measles/Rubella Surveillance, Directorate of Public Health/Communicable Diseases Control Center, Ministry of Health, Baghdad, Iraq

Abstract

Background: Typhoid fever is a serious infectious disease. In Iraq, the disease has a public health burden because it’s endemicity and there is an overestimation of the cases because the diagnosis almost depends on the Widal test.
Objectives: The study aimed to determine the occurrence of typhoid fever in four sentinel sites in Iraq and to assess Widal test sensitivity and specificity.
Materials and Methods: This cross-sectional observational study conducted in four districts in Iraq which has a population ranging from 170 000 to 431 000. A consecutive sample of (757) patients attended the outpatient or admitted to hospitals. Any Widal positive case, probable typhoid case and suspected typhoid case were included in the study. A questionnaire including demographic, clinical, laboratory and exposure data was filled for each suspected case. Confirmation of the diagnosis of typhoid fever was done by serological examination and culture (blood, urine or feces) for each patient included in the study. 
Results: The occurrence of typhoid fever (per 100 000 population) was 34, 9.4, 3.5, 0 in Al-Haweeja, Al-Hay, Al-Majar, and North Najaf districts respectively and this occurrence was lower in three study districts when compared with the same period of 2010 and 2011. The mean of the age of cases was 25.8 years ±16.03 and the male to female ratio of confirmed cases was 0.7:1. Also, this study showed that the sensitivity of the Widal test was 16.7% and the specificity was 36.2% when compared with culture results.
Conclusions: The incidence rate of typhoid fever was low in the four selected sites except for the Al-Haweeja district. The sensitivity and specificity of the Widal test were low. 

Keywords

Main Subjects

[1]      G. W. Brunette, CDC health information for international travel 2012: The Yellow Book. Oxford University Press, 2011.
[2]      D. C. N. Wu, “In this month’s Bulletin,” Bull World Heal. Organ, vol. 98, p. 1, 2020.
[3]      W. W. C. Topley, G. S. Wilson, M. T. Parker, L. H. Collier, and W. W. C. Topley, Topley & Wilson’s principles of bacteriology, virology, and immunity. London: Arnold, 1990.
[4]      E. C. Wam, C. N. Arrey, L. F. Sama, L. A. Agyingi, and A. N. Wam, “Comparative Study on the Use of Widal Test to Stool Culture in the Laboratory Diagnosis of Typhoid Fever in Holy Family Hospital Akum, North West Region of Cameroon,” Open Microbiol. J., vol. 13, no. 1, 2019.
[5]      R. M. Ebrahim, “Seasonal variation of typhoid fever in kirkuk city,” Al-Taqani, vol. 23, no. 5, pp. 94–98, 2010.
[6]      J. Crump, S. Luby, and E. Mintz, “The global burden of typhoid fever. Bull World Health Organ,” Bull. World Health Organ., vol. 82, pp. 346–353, May 2004, doi: 10.1590/S0042-96862004000500008.
[7]      T. Vos et al., “Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016,” Lancet, vol. 390, no. 10100, pp. 1211–1259, 2017.
[8]      S. Balasegaram et al., “Guidelines for the public health management of typhoid and paratyphoid in England: practice guidelines from the National Typhoid and Paratyphoid Reference Group,” J. Infect., vol. 65, no. 3, pp. 197–213, 2012.
[9]      G. C. Buckle, C. L. F. Walker, and R. E. Black, “Typhoid fever and paratyphoid fever: Systematic review to estimate global morbidity and mortality for 2010,” J. Glob. Health, vol. 2, no. 1, 2012.
[10]    G. Ameya, E. Atalel, and B. Yohannes, “Comparative study of Widal test against stool culture for typhoid fever suspected cases in southern Ethiopia,” Pathol. Lab. Med. Int., vol. Volume 9, pp. 1–7, Jan. 2017, doi: 10.2147/PLMI.S124155.
[11]    J. Dworkin et al., Disease Burden and Epidemiology of Typhoid Fever in Sulaimania, Iraqi Kurdistan. 2012.
[12]    K. Mellou et al., “A large waterborne gastroenteritis outbreak in central Greece, March 2012: challenges for the investigation and management,” Epidemiol. Infect., vol. 142, no. 1, pp. 40–50, 2014.
[13]    S. Yoo, H. Pai, J. Byeon, Y. H. Kang, S. Kim, and B. K. Lee, “Epidemiology of Salmonella enterica serotype typhi infections in Korea for recent 9 years: trends of antimicrobial resistance,” J. Korean Med. Sci., vol. 19, no. 1, pp. 15–20, 2004.
[14]    A. Adhikari, R. Rauniyar, P. P. Raut, K. Das Manandhar, and B. P. Gupta, “Evaluation of sensitivity and specificity of ELISA against Widal test for typhoid diagnosis in endemic population of Kathmandu,” BMC Infect. Dis., vol. 15, no. 1, p. 523, 2015.
[15]    S. Shukla, B. Patel, and D. S. Chitnis, “100 years of Widal test & its reappraisal in an endemic area.,” Indian J. Med. Res., vol. 105, pp. 53–57, 1997.
[16]    S. Sankar, “Epidemiological profile and outcome in typhoid fever.” Stanley Medical College, Chennai, 2018.
[17]    A. Mussa, “Reassessment of Widal test in the diagnosis of Typhoid Fever,” Diyala J. Med., vol. 1, no. 2, pp. 13–25, 2011.
[18]    M. L. Turgeon, Linne & Ringsrud’s Clinical Laboratory Science-E-Book: The Basics and Routine Techniques. Elsevier Health Sciences, 2014.
[19]    A.-R. D. T, “Evaluation of the Widal test in the diagnosis of typhoid fever,” Baghdad university, 1992.
[20]    A. M. Al-Abbasi and S. Al-Obaidi, “the level of Salmonella typhi antibodies among the Iraqi Subjects and their value in the diagnosis of typhoid fever,” J Comm Med, vol. 7, no. 2, pp. 113–119, 1994.
[21]    A. H. I., “enteric fever clinical and diagnostic evaluation,” Baghdad, 1993.
[22]    H. Al-Hossani, H. Abouzeid, M. M. Salah, H. M. Farag, and E. Fawzy, “Knowledge and practices of pregnant women about folic acid in pregnancy in Abu Dhabi, United Arab Emirates.,” East. Mediterr. Health J., vol. 16, no. 4, pp. 402–407, Apr. 2010.
[23]    M. N. Al-Khushali, “Typhoid & paratyphoid fevers in Salahaldin governorate,” Med. J. Tikrit, vol. 2, no. 142, pp. 107–112, 2008.